الإحصائيات الأساسية
| CIK | 1800682 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Cano Health, Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| July 8, 2024 |
EX-99.1 2 ef20032158ex1.htm EXHIBIT 1 CUSIP No: 13781Y202 SCHEDULE 13D Page 13 of 13 pages EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13D with respect to the common stock of Cano Health, Inc. dated as of July 8, 2024 is, and any amendments thereto (including amendments on Schedule 13G) signed by each of the undersigned shall be, filed on behalf of |
|
| July 8, 2024 |
US13781Y1111 / Cano Health Inc / Diameter Capital Partners LP - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment )* Cano Health, Inc. (Name of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securities) N/A (CUSIP No.) Diameter Capital Partners LP Attention: Shailini Rao 55 Hudson Yards, Suite 29B New York, NY 10001 (212) 655-1419 (Name, Address |
|
| July 8, 2024 |
EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13D. Each of them is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning |
|
| July 8, 2024 |
CANOQ / Cano Health, Inc. / Nut Tree Capital Management, LP - SC 13D Activist Investment SC 13D 1 ef20032183sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Cano Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 13781Y202** (CUSIP Number) Jared R. Nussbaum Nut Tree Capital Management, L.P. 55 Hudson Yards 22nd Floor New Y |
|
| July 8, 2024 |
US13781Y1111 / Cano Health Inc / Carlyle Group Inc. - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) Cano Health, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 13781Y103* (CUSIP Number) Jeffrey Ferguson The Carlyle Group 1001 Pennsylvania Avenue, NW Suite 220 South Washington, D.C. 20004 (202) 729-5626 (Name, Address and Teleph |
|
| July 8, 2024 |
EX-99.1 2 ef20032183ex1.htm EXHIBIT 1 EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13D with respect to the common stock of Cano Health, Inc. dated as of July 8, 2024 is, and any amendments thereto (including amendments on Schedule 13G) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the pro |
|
| July 8, 2024 |
EX-99.1 2 d862620dex991.htm EX-99.1 CUSIP No. 13781Y103 13D Page 1 of 2 pages Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13D. Each of them is responsible for the timely filing of such statement and any amendments thereto, |
|
| July 8, 2024 |
CANOQ / Cano Health, Inc. / Anchorage Capital Advisors, L.P. - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Cano Health, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 13781Y202** (CUSIP Number) Robert Dunleavy Anchorage Capital Advisors, L.P. 610 Broadway 6th Floor New York, NY 10012 212-432-4600 (Name, Address a |
|
| July 8, 2024 |
US13781Y1111 / Cano Health Inc / Squarepoint Ops LLC - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment )* Cano Health, Inc. (Name of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securities) N/A (CUSIP Number) Squarepoint Ops LLC Attention: Ronald Veith 250 West 55th Street, 32nd Floor New York, NY 10019 (646) 979-1370 (Name, Address |
|
| July 8, 2024 |
EX-99.1 2 d863961dex991.htm EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT The persons below hereby agree that the Schedule 13D to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13D, shall be filed jointly on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 19 |
|
| July 8, 2024 |
EX-99.2 3 d862620dex992.htm EX-99.2 Exhibit 2 POWER OF ATTORNEY The undersigned understands that, from time to time, the Carlyle Companies (defined below) are required to prepare, execute, and file certain federal and state securities laws filings. Know all by these presents, that the undersigned hereby constitutes and appoints each of Jeffrey Ferguson, Jeremy Anderson, Chintan Bhatt, Anne Frederi |
|
| July 1, 2024 |
Exhibit 10.2 CREDIT AGREEMENT dated as of June 28, 2024, among CANO HEALTH, LLC, as the Borrower, PRIMARY CARE (ITC) INTERMEDIATE HOLDINGS, LLC, as Holdings, THE LENDERS PARTY HERETO and WILMINGTON SAVINGS FUND SOCIETY, FSB, as Administrative Agent, Table of Contents Page ARTICLE 1 DEFINITIONS 1 SECTION 1.01 Defined Terms 1 SECTION 1.02 Classification of Loans and Borrowings 74 SECTION 1.03 Terms |
|
| July 1, 2024 |
LITIGATION TRUST AGREEMENT AND DECLARATION OF TRUST Exhibit 10.4 LITIGATION TRUST AGREEMENT AND DECLARATION OF TRUST This Litigation Trust Agreement, Declaration of Trust and Cooperation Agreement (as may be amended, supplemented or modified from time to time in accordance with the terms hereof, the “Agreement”), dated as of [•], 2024, is entered into by and among (a) Cano Health, Inc. and each of its undersigned affiliates (each, prior to the Effe |
|
| July 1, 2024 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION CANO HEALTH, INC. Exhibit 3.1 Execution Version AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CANO HEALTH, INC. The name of the corporation is Cano Health, Inc. (the “Corporation”). The Corporation was incorporated by the filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware on June 3, 2021 (the “Certificate of Incorporation”). This Amended and Restated Cert |
|
| July 1, 2024 |
Exhibit 2.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE —————————————————————————————— x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24-10164 (KBO) : Debtors.1 : : (Jointly Administered) : Re: Docket No. 1125 —————————————————————————————— x ORDER (I) CONFIRMING MODIFIED FOURTH AMENDED JOINT CHAPTER 11 PLAN OF REORGANIZATION OF CANO HEALTH, INC. AND ITS AFFILIATED |
|
| July 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 1, 2024 (June 28, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdictio |
|
| July 1, 2024 |
Amended and Restated By-laws of Cano Health, Inc. (a Delaware corporation) Exhibit 3.2 Execution Version Amended and Restated By-laws of Cano Health, Inc. (a Delaware corporation) Table of Contents Page Article I - Corporate Offices 1 1.1 Registered Office 1 1.2 Other Offices 1 Article II - Meetings of Stockholders 1 2.1 Place of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meetings 1 2.4 Notice of Business to be Brought Before a Meeting 2 2.5 Notice of Nominations for El |
|
| July 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-39289 Cano Health, Inc. (Exact name of registrant as specified in its chart |
|
| July 1, 2024 |
Exhibit 10.3 EXECUTION VERSION WARRANT AGREEMENT This AGREEMENT (this “Agreement”), dated as of June 28, 2024 (the “Effective Date”), by and between Cano Health, Inc., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”) and transfer agent of the Company (in such capacity, the “Trans |
|
| July 1, 2024 |
CANO HEALTH, INC. SHAREHOLDERS’ AGREEMENT Exhibit 10.1 Execution Version CANO HEALTH, INC. SHAREHOLDERS’ AGREEMENT This Shareholders’ Agreement (this “Agreement”) is made and entered into as of June 28, 2024 (the “Reorganization Date”), by and among Cano Health, Inc., a Delaware corporation (the “Corporation”), and the Holders (as defined below) from time to time party hereto. The Corporation and the Holders are referred to collectively h |
|
| July 1, 2024 |
Exhibit 99.1 PRIVILEGED AND CONFIDENTIAL CANO HEALTH ANNOUNCES SUCCESSFUL EMERGENCE FROM CHAPTER 11 Exits Court-Supervised Restructuring Process with Significantly Deleveraged Balance Sheet and New Financing to Support Operations On Track to Achieve $290 million of Annualized Cost Reductions by the End of 2024 MIAMI, FL [June 28, 2024] — Cano Health, Inc. (“Cano Health” or the “Company”), a leadin |
|
| June 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 28, 2024 (June 27, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdicti |
|
| June 28, 2024 |
Exhibit 99.3 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE ————————————————————————— x In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : : Debtors.1 : (Jointly Administered) ————————————————————————— x NOTICE OF FILING OF THIRD SUPPLEMENT TO PLAN SUPPLEMENT IN CONNECTION WITH MODIFIED FOURTH AMENDED JOINT CHAPTER 11 PLAN OF REORGANIZATION OF CANO HEAL |
|
| June 28, 2024 |
Exhibit 99.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE —————————————————— x In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : : Debtors.1 : (Jointly Administered) —————————————————— x NOTICE OF FILING OF SECOND SUPPLEMENT TO PLAN SUPPLEMENT IN CONNECTION WITH FOURTH AMENDED JOINT CHAPTER 11 PLAN OF REORGANIZATION OF CANO HEALTH, INC. AND ITS AFFIL |
|
| June 28, 2024 |
Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE ————————————————————————— x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : Debtors.1 : (Jointly Administered) : : Re: Docket No. 498, 671, 773, 829, 864 ———————————————————————— x THIS PLAN HAS NOT YET BEEN APPROVED BY THE BANKRUPTCY COURT. THIS IS NOT AN OFFER OR SOLICITATION OF AN OFFER OR ANY OTHER S |
|
| June 21, 2024 |
Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE x In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : : Debtors.1 : (Jointly Administered) x NOTICE OF FILING OF FIRST SUPPLEMENT TO PLAN SUPPLEMENT IN CONNECTION WITH FOURTH AMENDED JOINT CHAPTER 11 PLAN OF REORGANIZATION OF CANO HEALTH, INC. AND ITS AFFILIATED DEBTORS PLEASE TAKE NOTICE that b |
|
| June 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 21, 2024 (June 20, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdicti |
|
| June 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 17, 2024 (June 14, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdicti |
|
| June 17, 2024 |
Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE ————————————————————————— x In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : : Debtors.1 : (Jointly Administered) ————————————————————————— x NOTICE OF FILING OF PLAN SUPPLEMENT IN CONNECTION WITH FOURTH AMENDED JOINT CHAPTER 11 PLAN OF REORGANIZATION OF CANO HEALTH, INC. AND ITS AFFILIATED DEBTORS P |
|
| June 4, 2024 |
EX-99.1 Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF Delaware In Re. Cano Health, Inc. § Case No. 24-10164 § § Lead Case No. 24-10164 Debtor(s) § Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 04/30/2024 Petition Date: 02/04/2024 Months Pending: 3 Industry Classification: 6 2 1 1 Reporting Method: Accrual Basis Cash Basis Debtor’s Full-Time Employees (c |
|
| June 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 4, 2024 (June 3, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdiction |
|
| May 22, 2024 |
Exhibit 99.1 Solicitation Version UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE —————————————————————————————— x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : Debtors.1 : (Jointly Administered) : : Re: Docket No. 498, 671, 773, 829 —————————————————————————————— x THIS PLAN HAS NOT YET BEEN APPROVED BY THE BANKRUPTCY COURT. THIS IS NOT AN OFFER OR SOLICITATION |
|
| May 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 22, 2024 (May 21, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdiction |
|
| May 22, 2024 |
Exhibit 99.2 Solicitation Version IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE —————————————————————————————— x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : Debtors.1 : (Jointly Administered) : : Re: Docket No. 864 —————————————————————————————— x DISCLOSURE STATEMENT FOR FOURTH AMENDED JOINT CHAPTER 11 PLAN OF REORGANIZATION OF CANO HEALTH, I |
|
| May 22, 2024 |
Exhibit 99.3 Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan Emergence from Chapter 11 Expected in Third Quarter of 2024 MIAMI, May 21, 2024 — Cano Health, Inc. (NYSE: CANO) (“Cano Health” or the “Company”), a leading value-based primary care provider and population health company, today announced a global ag |
|
| May 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 21, 2024 Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdiction of incorporati |
|
| May 21, 2024 |
Exhibit 99.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE —————————————————————————————— x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : Debtors.1 : (Jointly Administered) : : —————————————————————————————— x [PROPOSED] DISCLOSURE STATEMENT FOR FOURTH AMENDED JOINT CHAPTER 11 PLAN OF REORGANIZATION OF CANO HEALTH, INC. AND ITS AFFILIATED DEBTOR |
|
| May 21, 2024 |
EX-99.1 Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE —————————————————————————————— x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : Debtors.1 : (Jointly Administered) : : Re: Docket No. 498, 671, 773, 829 —————————————————————————————— x THIS PLAN HAS NOT YET BEEN APPROVED BY THE BANKRUPTCY COURT. THIS IS NOT AN OFFER OR SOLICITATION OF AN OFFE |
|
| May 17, 2024 |
Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : Debtors.1 : (Jointly Administered) : : Re: Docket No. 498, 671, 773 x THIS PLAN HAS NOT YET BEEN APPROVED BY THE BANKRUPTCY COURT. THIS IS NOT AN OFFER OR SOLICITATION OF AN OFFER OR ANY OTHER SOLICITATION WITH RESPECT TO ANY SECURITIES OR A SO |
|
| May 17, 2024 |
Exhibit 99.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : Debtors.1 : (Jointly Administered) : : Re: Docket No. [●] x THIS PROPOSED DISCLOSURE STATEMENT HAS NOT YET BEEN APPROVED BY THE BANKRUPTCY COURT. THIS IS NOT AN OFFER OR SOLICITATION OF AN OFFER OR ANY OTHER SOLICITATION WITH RESPECT TO ANY |
|
| May 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 17, 2024 Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdiction of incorporati |
|
| May 10, 2024 |
Exhibit 10.8 Amendment to Employment Agreement This Amendment to Employment Agreement (the “Amendment”) is made among Cano Health, LLC (the “Company”), Cano Health, Inc., a Delaware corporation (the “Parent”), and Eladio Gil (the “Executive”), effective as of March 28, 2024 (the “Effective Date”). The Company, Parent and the Executive may each be referred to as a “Party” and collectively as the “P |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39289 Cano Health, Inc. (E |
|
| May 7, 2024 |
EX-99.1 Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE —————————————————————————————— x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : Debtors.1 : (Jointly Administered) : : Re: Docket No. 498, 671 —————————————————————————————— x THIS PLAN HAS NOT YET BEEN APPROVED BY THE BANKRUPTCY COURT. THIS IS NOT AN OFFER OR SOLICITATION OF AN OFFER OR ANY OTH |
|
| May 7, 2024 |
EX-99.2 Exhibit 99.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE —————————————————————————————— x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : Debtors.1 : (Jointly Administered) : : Re: Docket No. [•] —————————————————————————————— x [PROPOSED] DISCLOSURE STATEMENT FOR SECOND AMENDED JOINT CHAPTER 11 PLAN OF REORGANIZATION OF CANO HEALTH, INC |
|
| May 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2024 (May 6, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdiction o |
|
| May 2, 2024 |
EX-99.1 Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF Delaware In Re. Cano Health, Inc. § Case No. 24-10164 § § Lead Case No. 24-10164 Debtor(s) § Jointly Administered Monthly Operating Report Chapter 11 Reporting Period Ended: 03/31/2024 Petition Date: 02/04/2024 Months Pending: 2 Industry Classification: 6 2 1 1 Reporting Method: Accrual Basis Cash Basis Debtor’s Full-Time Employees (c |
|
| May 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 2, 2024 (May 1, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdiction o |
|
| April 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 22, 2024 Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdiction of incorpora |
|
| April 22, 2024 |
Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE —————————————————————————————— x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : Debtors.1 : (Jointly Administered) : Re: Docket No. 498 —————————————————————————————— x THIS PLAN HAS NOT YET BEEN APPROVED BY THE BANKRUPTCY COURT. THIS IS NOT AN OFFER OR SOLICITATION OF AN OFFER OR ANY OTHER SOLICITATI |
|
| April 22, 2024 |
Exhibit 99.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : Debtors.1 : (Jointly Administered) : : Re: Docket No. [●] x [PROPOSED] DISCLOSURE STATEMENT FOR AMENDED JOINT CHAPTER 11 PLAN OF REORGANIZATION OF CANO HEALTH, INC. AND ITS AFFILIATED DEBTORS WEIL, GOTSHAL & MANGES LLP Gary T. Holtzer Jessi |
|
| April 22, 2024 |
Exhibit 99.3 Cano Health – Long Range Plan Update April 2024 Disclaimer GENERAL: This presentation (“Presentation”) is for informational purposes only to assist investors, prospective investors and other parties (“Recipients”) in making their own evaluation with respect to Cano Health, Inc. (“Cano Health” or the “Company”, “our” or words of similar import). The information contained herein does no |
|
| April 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 11, 2024 (April 3, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdict |
|
| April 11, 2024 |
Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF Delaware In Re. Cano Health, Inc. § Case No. 24-10164 § § Lead Case No. 24-10164 Debtor(s) § Jointly Administered Chapter 11 Reporting Period Ended: 02/29/2024 Petition Date: 02/04/2024 Months Pending: 1 Industry Classification: 6 2 1 1 Reporting Method: Accrual Basis Cash Basis Debtor’s Full-Time Employees (current): 0 Debtor’s Full-Time Emp |
|
| April 4, 2024 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 12)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, Florida 33178 Tel: (855) 226- |
|
| April 1, 2024 |
. 2021 Employee Stock Purchase Plan Exhibit 10.16 THIRD AMENDMENT TO CANO HEALTH, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN THIS THIRD AMENDMENT is made by Cano Health, Inc. (the “Company”) for the purpose of amending the Cano Health, Inc. 2021 Employee Stock Purchase Plan (the “ESPP” or the “Plan”). WITNESSETH: WHEREAS, the Company maintains the ESPP, which has been approved and adopted by the Company’s board of directors (the “Board” |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39289 Cano Health, Inc. (Exact |
|
| April 1, 2024 |
Exhibit 10.18 Amendment to Employment Agreement This Amendment to Employment Agreement (the “Amendment”) is made among Cano Health, LLC (the “Company”), Cano Health, Inc., a Delaware corporation (the “Parent”), and Eladio Gil (the “Executive”), effective as of March 28, 2024 (the “Effective Date”). The Company, Parent and the Executive may each be referred to as a “Party” and collectively as the “ |
|
| April 1, 2024 |
Exhibit 21.1 Subsidiaries of Cano Health, Inc. Name of Subsidiary Jurisdiction of Incorporation of Organization Primary Care (ITC) Intermediate Holdings, LLC Delaware, U.S. Cano Health, LLC Florida, U.S. Complete Medical Billing and Coding Services, LLC Florida, U.S. Cano Pharmacy, LLC Florida, U.S. Comfort Pharmacy 2, LLC Florida, U.S. Physicians Partners Group Merger, LLC Florida, U.S. Cano Heal |
|
| April 1, 2024 |
Exhibit 10.15 CANO HEALTH, INC. EXECUTIVE COMPENSATION RECOVERY POLICY Adopted as of September 13, 2023 Cano Health, Inc., a Delaware corporation (the “Company”), has adopted the following Executive Compensation Recovery Policy (this “Policy”): 1. Overview: The Policy sets forth the circumstances and procedures under which the Company shall recover Erroneously Awarded Compensation from current and |
|
| March 26, 2024 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 11)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, Florida 33178 Tel: (855) 226- |
|
| March 25, 2024 |
Exhibit 99.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE ——————————————————————— x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24–10164 (KBO) : Debtors.1 : (Jointly Administered) : : Re: Docket No. [•] ——————————————————————— x [PROPOSED] DISCLOSURE STATEMENT FOR JOINT CHAPTER 11 PLAN OF REORGANIZATION OF CANO HEALTH, INC. AND ITS AFFILIATED DEBTORS WEIL, GO |
|
| March 25, 2024 |
Exhibit 99.1 UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE x : In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24– 10164 (KBO) : Debtors.1 : (Jointly Administered) : x THIS PLAN HAS NOT YET BEEN APPROVED BY THE BANKRUPTCY COURT. THIS IS NOT AN OFFER OR SOLICITATION OF AN OFFER OR ANY OTHER SOLICITATION WITH RESPECT TO ANY SECURITIES OR A SOLICITATION OF ACCEPTANCES OF A CHAPTER 11 |
|
| March 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 25, 2024 (March 22, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdic |
|
| March 22, 2024 |
As filed with the Securities and Exchange Commission on March 22, 2024 As filed with the Securities and Exchange Commission on March 22, 2024 Registration No. |
|
| March 22, 2024 |
As filed with the Securities and Exchange Commission on March 22, 2024 As filed with the Securities and Exchange Commission on March 22, 2024 Registration No. |
|
| March 22, 2024 |
As filed with the Securities and Exchange Commission on March 22, 2024 As filed with the Securities and Exchange Commission on March 22, 2024 Registration No. |
|
| March 22, 2024 |
As filed with the Securities and Exchange Commission on March 22, 2024 As filed with the Securities and Exchange Commission on March 22, 2024 Registration No. |
|
| March 22, 2024 |
As filed with the Securities and Exchange Commission on March 22, 2024 As filed with the Securities and Exchange Commission on March 22, 2024 Registration No. |
|
| March 22, 2024 |
As filed with the Securities and Exchange Commission on March 22, 2024 As filed with the Securities and Exchange Commission on March 22, 2024 Registration No. |
|
| March 22, 2024 |
As filed with the Securities and Exchange Commission on March 22, 2024 As filed with the Securities and Exchange Commission on March 22, 2024 Registration No. |
|
| March 22, 2024 |
As filed with the Securities and Exchange Commission on March 22, 2024 As filed with the Securities and Exchange Commission on March 22, 2024 Registration No. |
|
| March 18, 2024 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 10)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, Florida 33178 Tel: (855) 226- |
|
| March 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING 001-39289 (Commission File Number) (Check one): Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR ☐ For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Repor |
|
| March 12, 2024 |
[Remainder of Page Intentionally Left Blank] EX-99.1 Exhibit 99.1 ATTENTION DIRECT AND INDIRECT HOLDERS OF, AND PROSPECTIVE HOLDERS OF STOCK ISSUED BY CANO HEALTH, INC: Upon the motion, dated February 5, 2024 (the “Motion”) of Cano Health, Inc. and certain of its subsidiaries, as debtors and debtors in possession in the chapter 11 cases (collectively, the “Debtors”) captioned as In re Cano Health, Inc., et al., No. 24-10164 (KBO) (the “Chapt |
|
| March 12, 2024 |
EX-99.2 Exhibit 99.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE ————————————————————— x In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24-10164 (KBO) : : Debtors.1 : (Jointly Administered) ————————————————————— x NOTICES, RESTRICTIONS, AND OTHER PROCEDURES REGARDING OWNERSHIP AND TRANSFERS OF INTERESTS IN THE DEBTORS TO ALL PERSONS OR ENTITIES THAT BENEFICIALLY |
|
| March 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 12, 2024 (March 5, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdict |
|
| March 11, 2024 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D/A Activist Investment SC 13D/A 1 d799939dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 9)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, |
|
| March 5, 2024 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D/A Activist Investment SC 13D/A 1 d740451dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, |
|
| February 26, 2024 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D/A Activist Investment SC 13D/A 1 d776064dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, |
|
| February 16, 2024 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D/A Activist Investment SC 13D/A 1 d793671dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, |
|
| February 13, 2024 |
US13781Y2028 / CANO HEALTH INC / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0523-canohealthincclassa.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Cano Health, Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 13781Y202 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to |
|
| February 12, 2024 |
[Remainder of Page Intentionally Left Blank] EX-99.1 Exhibit 99.1 ATTENTION DIRECT AND INDIRECT HOLDERS OF, AND PROSPECTIVE HOLDERS OF STOCK ISSUED BY CANO HEALTH, INC.: Upon the motion, dated February 5, 2024 (the “Motion”) of Cano Health, Inc. and certain of its subsidiaries, as debtors and debtors in possession in the chapter 11 cases (collectively, the “Debtors”) captioned as In re Cano Health, Inc., et al., No. 24-10164 (KBO) (the “Chap |
|
| February 12, 2024 |
EX-99.2 Exhibit 99.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE x In re : Chapter 11 : CANO HEALTH, INC., et al., : Case No. 24-10164 (KBO) : : Debtors.1 : (Jointly Administered) x NOTICES, RESTRICTIONS, AND OTHER PROCEDURES REGARDING OWNERSHIP AND TRANSFERS OF INTERESTS IN THE DEBTORS TO ALL PERSONS OR ENTITIES THAT BENEFICIALLY OWN EQUITY INTERESTS IN THE DEBTORS: Pursuan |
|
| February 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 9, 2024 (February 7, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other juri |
|
| February 12, 2024 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D/A Activist Investment SC 13D/A 1 d767815dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, |
|
| February 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 7, 2024 Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdiction of incorpo |
|
| February 7, 2024 |
CANO / Cano Health, Inc. / Cooperstone Elliot - SC 13D/A Activist Investment SC 13D/A 1 d50098dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 14)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.01 par value per share (Title of Class of Securities |
|
| February 7, 2024 |
Exhibit 10.1 EXECUTION VERSION SENIOR SECURED SUPERPRIORITY DEBTOR-IN-POSSESSION CREDIT AGREEMENT dated as of February 7, 2024, among CANO HEALTH, LLC, a Debtor and a Debtor-in-Possession under Chapter 11 of the Bankruptcy Code, as the Borrower, PRIMARY CARE (ITC) INTERMEDIATE HOLDINGS, LLC, a Debtor and a Debtor-in-Possession under Chapter 11 of the Bankruptcy Code, as Holdings, THE LENDERS PARTY |
|
| February 6, 2024 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange (the 'NYSE' or the 'Exchange') hereby notifies the Securities and Exchange Commission (the 'Commission') of its intention to remove the Class A Common Stock (the "Common Stock") of Cano Health, Inc. |
|
| February 6, 2024 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D/A Activist Investment SC 13D/A 1 d728326dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, |
|
| February 5, 2024 |
Exhibit 10.2 Senior Executive KERP Privileged & Confidential January 31, 2024 [EMPLOYEE NAME] Cano Health, LLC 9725 NW 117th Ave, 2nd Floor Miami, FL 33178 Via Electronic Mail Re: Cano Health - Key Employee Retention Bonus Dear [•]: In recognition of your continuing key role at Cano Health, LLC (together with its subsidiaries, the “Company”), you shall be eligible to earn a retention bonus upon th |
|
| February 5, 2024 |
EX-10.4 Exhibit 10.4 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is made among Cano Health, LLC (the “Company”), Cano Health, Inc., a Delaware corporation (the “Parent”), and Eladio Gil (the “Executive”), effective as of January 1, 2024 (the “Effective Date”). WHEREAS, upon the Effective Date the Company desires to employ the Executive, and the Executive desir |
|
| February 5, 2024 |
EX-10.5 Exhibit 10.5 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is made among Cano Health, LLC (the “Company”), Cano Health, Inc., a Delaware corporation (the “Parent”), and Robert Camerlinck (the “Executive”), effective as of January 1, 2024 (the “Effective Date”). WHEREAS, upon the Effective Date the Company desires to employ the Executive, and the Executiv |
|
| February 5, 2024 |
EX-99.2 Exhibit 99.2 Cano Health Enters Restructuring Support Agreement with a Significant Majority of its Lenders to Strengthen Financial Position Positions the Company to Advance Its Ongoing Transformation Plan Designed to Significantly Reduce Costs, Enhance Productivity, and Improve Cash Flow Receives Commitment for $150 Million in New Capital Ensures Patients Continue to Receive High-Quality C |
|
| February 5, 2024 |
EX-10.1 Exhibit 10.1 EXECUTION VERSION THIS RESTRUCTURING SUPPORT AGREEMENT IS NOT AN OFFER OR SOLICITATION OF AN OFFER OR ANY OTHER SOLICITATION WITH RESPECT TO ANY SECURITIES OR A SOLICITATION OF ACCEPTANCES OF A CHAPTER 11 PLAN WITHIN THE MEANING OF SECTIONS 1125 AND 1126 OF THE BANKRUPTCY CODE. ANY SUCH OFFER OR SOLICITATION WILL COMPLY WITH ALL APPLICABLE SECURITIES LAWS AND/OR PROVISIONS OF |
|
| February 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 5, 2024 (February 5, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other juri |
|
| February 5, 2024 |
NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings Exhibit 99.1 NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings MIAMI, FL, February 5, 2024 /PRNewswire/— Cano Health, Inc. (NYSE: CANO) (“Cano Health” or the “Company”) announced today that on February 5, 2024, the New York Stock Exchange (the “NYSE”) notified the Company that the NYSE had determined to (a) commence proceedings to delist the Company’s Class A co |
|
| February 5, 2024 |
EX-10.6 Exhibit 10.6 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is made among Cano Health, LLC (the “Company”), Cano Health, Inc., a Delaware corporation (the “Parent”), and David Armstrong (the “Executive”), effective as of January 1, 2024 (the “Effective Date”). WHEREAS, upon the Effective Date the Company desires to employ the Executive, and the Executive |
|
| February 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 5, 2024 (January 31, 2024) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other juri |
|
| February 5, 2024 |
EX-10.3 Exhibit 10.3 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is made among Cano Health, LLC (the “Company”), Cano Health, Inc., a Delaware corporation (the “Parent”), and deMarquette Kent (the “Executive”), effective as of January 1, 2024 (the “Effective Date”). WHEREAS, upon the Effective Date the Company desires to employ the Executive, and the Executive |
|
| February 5, 2024 |
February 2024 Cano Health – Business Plan Presentation Exhibit 99.1 Disclaimer GENERAL: This presentation (“Presentation”) is for informational purposes only to assist investors, prospective investors and other parties (“Recipients”) in making their own evaluation with respect to Cano Health, Inc. (“Cano Health” or the “Company”, “our” or words of similar import). The information contained herein |
|
| January 31, 2024 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, Florida 33178 Tel: (855) 226-6 |
|
| January 26, 2024 |
CANO / Cano Health, Inc. / Cooperstone Elliot - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 13)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.01 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) EL |
|
| January 24, 2024 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D/A Activist Investment SC 13D/A 1 d79036dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, F |
|
| January 12, 2024 |
CANO / Cano Health, Inc. / Cooperstone Elliot - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 12)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.01 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) EL |
|
| January 12, 2024 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D/A Activist Investment SC 13D/A 1 d60988dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, F |
|
| December 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 29, 2023 (December 22, 2023) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other ju |
|
| December 29, 2023 |
EX-99.1 Exhibit 99.1 Cano Health Receives NYSE Notice of Non-Compliance with Market Capitalization Criteria Accelerates Transformation Plan, Now Targeting $290 million of Cost Reductions MIAMI, FL, December 29, 2023 /PRNewswire/-Cano Health, Inc. (NYSE: CANO) (“Cano Health” or the “Company”) announced today that it was notified by NYSE Regulation Inc. (the “NYSE”) that it is not in compliance with |
|
| December 29, 2023 |
CANO / Cano Health, Inc. / Cooperstone Elliot - SC 13D/A Activist Investment SC 13D/A 1 d678148dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 11)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.01 par value per share (Title of Class of Securitie |
|
| December 21, 2023 |
CANO / Cano Health, Inc. / Hernandez Marlow - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 6)* Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value (Title of Class of Securities) 13781Y 103 (CUSIP Number) Dr. Marlow Hernandez c/o Cano Health, Inc. 9725 NW 117th Avenue, Suite 200 Miami, Florida 33178 (203) 422-7718 |
|
| December 19, 2023 |
CANO / Cano Health, Inc. / Cooperstone Elliot - SC 13D/A Activist Investment SC 13D/A 1 d810813dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 10)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.01 par value per share (Title of Class of Securitie |
|
| December 19, 2023 |
TERMINATION OF JOINT FILING AND SOLICITATION AGREEMENT November 7, 2023 EX-99.1 2 d810813dex991.htm EX-99.1 Exhibit 99.1 TERMINATION OF JOINT FILING AND SOLICITATION AGREEMENT November 7, 2023 Each of the undersigned is a party to that certain Joint Filing and Solicitation Agreement, dated as of May 18, 2023 (the “Joint Filing and Solicitation Agreement”). In accordance with Section 11 of the Joint Filing and Solicitation Agreement, each of the undersigned hereby agre |
|
| December 18, 2023 |
EX-99.1 Exhibit 99.1 Cano Health Announces Appointment of Two New Independent Directors Patricia Ferrari and Carol Flaton to Enhance the Board’s and Management’s Ongoing Strategic, Operational and Financing Initiatives Cano Health, Inc. (“Cano Health” or the “Company”) (NYSE: CANO), a leading value-based primary care provider and population health company, today announced the appointment of Patric |
|
| December 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 18, 2023 (December 18, 2023) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other ju |
|
| December 18, 2023 |
EX-10.1 Exhibit 10.1 December 18, 2023 Ms. Patricia K. Ferrari 29 Hopp Ground Lane Bedford, NY 10506 Dear Ms. Ferrari: This Director Services Agreement (the “Agreement”) sets out the terms upon which you, Ms. Patricia K. Ferrari (“Director” or “you”), have agreed to act as an independent director on the board of directors (the “Board”) of Cano Health, Inc., a Delaware corporation (the “Company”), |
|
| December 18, 2023 |
EX-10.2 Exhibit 10.2 December 18, 2023 Ms. Carol L. Flaton 210 Mudge Pond Road Sharon, CT 06069 Dear Ms. Flaton: This Director Services Agreement (the “Agreement”) sets out the terms upon which you, Ms. Carol L. Flaton (“Director” or “you”), have agreed to act as an independent director on the board of directors (the “Board”) of Cano Health, Inc., a Delaware corporation (the “Company”), with effec |
|
| November 20, 2023 |
EX-99.3 4 tm2330855d2ex3.htm EXHIBIT 3 Exhibit 3 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned Reporting Persons hereby agrees to the joint filing, along with all other such Reporting Persons, on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Class A |
|
| November 20, 2023 |
EX-99.2 3 tm2330855d2ex2.htm EXHIBIT 2 Exhibit 2 POWER OF ATTORNEY FOR CERTAIN REGULATORY FILINGS INCLUDING CERTAIN FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND THE INVESTMENT ADVISERS ACT OF 1940 I, David E. Shaw, hereby make, constitute, and appoint each of: Edward Fishman, Julius Gaudio, Martin Lebwohl, Maximilian Stone, David Sweet, Nathan Thomas, and Eric Wepsic, acting individually, |
|
| November 20, 2023 |
CANO / Cano Health Inc - Class A / D. E. SHAW & CO, L.P. - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Cano Health, Inc. (Name of Issuer) Class A common stock, $0.01 par value per share (Title of Class of Securities) 13781Y202 (CUSIP Number) November 10, 2023 (Date of Event Which Requires Filing of this Statement) Check the following box to designate the rule pursuant to which the Schedu |
|
| November 20, 2023 |
EX-99.1 2 tm2330855d2ex1.htm EXHIBIT 1 Exhibit 1 POWER OF ATTORNEY FOR CERTAIN REGULATORY FILINGS INCLUDING CERTAIN FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934 AND THE INVESTMENT ADVISERS ACT OF 1940 I, David E. Shaw, hereby make, constitute, and appoint each of: Edward Fishman, Julius Gaudio, Martin Lebwohl, Maximilian Stone, David Sweet, Nathan Thomas, and Eric Wepsic, acting individually, |
|
| November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 15, 2023 (November 9, 2023) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jur |
|
| November 13, 2023 |
66444216;16 DMUS 190520716-12.102113.0045 ASSET PURCHASE AGREEMENT DATED AS OF December 9, 2022 AMONG CANO HEALTH, LLC CANO HEALTH, INC., THE SELLERS PARTY HERETO AND DEMARQUETTE KENT -ii- 66444216;16 DMUS 190520716-12.102113.0045 TABLE OF EXHIBITS EXHIBIT A DEFINITIONS EXHIBIT B SPECIFICALLY EXCLUDED ASSETS EXHIBIT C PURCHASE CONSIDERATION ALLOCATION EXHIBIT D GENERAL COMPLIANCE ATTESTATION EXHIB |
|
| November 13, 2023 |
NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING 001-39289 (Commission File Number) (Check one): Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☒ Form 10-D ☐ Form N-CEN ☐ Form N-CSR ☐ For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transiti |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39289 Cano Health, Inc |
|
| November 13, 2023 |
Employment Agreement, by and among Cano Health, LLC Exhibit 10.13 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT WHEREAS, this First Amendment to the Employment Agreement is made and entered into effective as of April 5, 2023 (the “Effective Date”) by and between Cano Health, LLC (“Employer” or “Company” or “Cano Health”) a Florida limited liability company and deMarquette Kent (“Executive”). WHEREAS, Company and Executive entered into that certain Agreem |
|
| November 13, 2023 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange ("NYSE" or the "Exchange") hereby notifies the Securities and Exchange Commission (the "Commission") of its intention to remove the entire class of Redeemable warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (the "Warrants") of Cano Health, Inc. |
|
| November 9, 2023 |
Cano Health Announces Financial Results for the Third Quarter 2023 Exhibit 99.1 Cano Health Announces Financial Results for the Third Quarter 2023 MIAMI, November 9, 2023 /PRNewswire/– Cano Health, Inc. (“Cano Health” or the “Company”) (NYSE: CANO), a leading value-based primary care provider and population health company, today announced financial results for the third quarter ended September 30, 2023. Executive Management Highlights •Third quarter results refle |
|
| November 9, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2023 Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdiction of incorpo |
|
| November 9, 2023 |
1 Cano Health 3Q23 Financial Supplement November 9, 2023 2 Disclaimer GENERAL: This presentation (“Presentation”) is for informational purposes only to assist investors, prospective investors and other parties (“Recipients”) in making their own evaluation with respect to Cano Health, Inc. |
|
| November 9, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2023 Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware (State or other jurisdiction of incorporation or o |
|
| November 9, 2023 |
Cano Health Announces Financial Results for the Third Quarter 2023 Exhibit 99.1 Cano Health Announces Financial Results for the Third Quarter 2023 MIAMI, November 9, 2023 /PRNewswire/– Cano Health, Inc. (“Cano Health” or the “Company”) (NYSE: CANO), a leading value-based primary care provider and population health company, today announced financial results for the third quarter ended September 30, 2023. Executive Management Highlights • Third quarter results refl |
|
| November 7, 2023 |
TERMINATION OF JOINT FILING AND SOLICITATION AGREEMENT November 7, 2023 EX-99.P 2 ef20014171ex99-p.htm EXHIBIT P EXHIBIT P TERMINATION OF JOINT FILING AND SOLICITATION AGREEMENT November 7, 2023 Each of the undersigned is a party to that certain Joint Filing and Solicitation Agreement, dated as of May 18, 2023 (the “Joint Filing and Solicitation Agreement”). In accordance with Section 11 of the Joint Filing and Solicitation Agreement, each of the undersigned hereby ag |
|
| November 7, 2023 |
SC 13D/A 1 sc13da91375600210272023.htm AMENDMENT NO. 9 TO THE SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 9)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value p |
|
| November 7, 2023 |
CANO / Cano Health Inc - Class A / STERNLICHT BARRY S - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 12)* Cano Health, Inc. (Name of Issuer) Class A common stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) Michael Racich 1601 Washington Avenue, Suite 800 Miami Beach, Florida 33139 (203) 422-7718 (Name, Address and Te |
|
| November 7, 2023 |
SC 13D/A 1 sc13da91377800210272023.htm AMENDMENT NO. 9 TO THE SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 9)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value p |
|
| November 7, 2023 |
TERMINATION OF JOINT FILING AND SOLICITATION AGREEMENT November 7, 2023 EX-99.1 2 ex991to13da913778002102723.htm JFSA TERMINATION AGREEMENT, DATED NOVEMBER 7, 2023 Exhibit 99.1 TERMINATION OF JOINT FILING AND SOLICITATION AGREEMENT November 7, 2023 Each of the undersigned is a party to that certain Joint Filing and Solicitation Agreement, dated as of May 18, 2023 (the “Joint Filing and Solicitation Agreement”). In accordance with Section 11 of the Joint Filing and Sol |
|
| November 7, 2023 |
TERMINATION OF JOINT FILING AND SOLICITATION AGREEMENT November 7, 2023 Exhibit 99.1 TERMINATION OF JOINT FILING AND SOLICITATION AGREEMENT November 7, 2023 Each of the undersigned is a party to that certain Joint Filing and Solicitation Agreement, dated as of May 18, 2023 (the “Joint Filing and Solicitation Agreement”). In accordance with Section 11 of the Joint Filing and Solicitation Agreement, each of the undersigned hereby agrees that the Joint Filing and Solicit |
|
| November 2, 2023 |
Cano Health Announces Consummation of Previously-Announced 1-for-100 Reverse Stock Split Exhibit 99.1 Cano Health Announces Consummation of Previously-Announced 1-for-100 Reverse Stock Split MIAMI, FL, November 2, 2023 /PRNewswire/— Cano Health, Inc. (“Cano Health” or the “Company”) (NYSE: CANO) today announced that it completed a 1-for-100 reverse stock split of its shares Class A common stock and Class B common stock, including both issued and outstanding and unissued shares, follow |
|
| November 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 2, 2023 (November 2, 2023) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other juri |
|
| November 2, 2023 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF CANO HEALTH, INC. Cano Health, Inc. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware as set forth in Title 8 of the Delaware Code (the “DGCL”), hereby certifies as follows: 1. This Certificate of Amendment (the “Certificate of Amendment”) amends the provisions |
|
| October 16, 2023 |
DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| October 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 13, 2023 (October 9, 2023) CANO HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-39289 98-1524224 (State or other jurisdiction of incorporation |
|
| October 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 5, 2023 Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisdiction of incorpor |
|
| October 6, 2023 |
Cano Health Files Preliminary Proxy Statement with the SEC to initiate plan for Reverse Stock Split Exhibit 99.1 Cano Health Files Preliminary Proxy Statement with the SEC to initiate plan for Reverse Stock Split MIAMI, FL, October 5, 2023 /PRNewswire/— Cano Health, Inc. (“Cano Health” or the “Company”) (NYSE: CANO) today announced that it has filed a preliminary proxy statement with the SEC regarding a special stockholders’ meeting to authorize Cano Health’s Board of Directors to effect a rever |
|
| October 5, 2023 |
PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| September 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2023 (September 26, 2023) CANO HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-39289 98-1524224 (State or other jurisdiction of incorpor |
|
| September 29, 2023 |
Employment Agreement, dated as of May 19, 2023, by and between Cano Health, LLC and Mr. Eladio Gil. Exhibit 10.2 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”), dated as of May 19th, 2023 is effective as of the Commencement Date (defined below) between Cano Health, LLC (d/b/a Cano Health), a Florida limited liability company (the “Company”), and Eladio Gil, an individual (the “Executive”). 1. Employment. (a) Term. The Company hereby employs the Executive, and the Executive here |
|
| September 29, 2023 |
EX-99.1 Exhibit 99.1 On September 25, 2023, Cano Health, LLC (“Cano Health”), a wholly-owned subsidiary of Cano Health, Inc. (the “Company”), entered into an Asset Purchase Agreement (the “Agreement”) with Primary Care Holdings II, LLC, a wholly owned subsidiary of Humana Inc. (“CenterWell”), Cano Health Texas, PLLC and Cano Health Nevada, PLLC (together with Cano Health, the “Sellers” and each, a |
|
| September 29, 2023 |
Exhibit 99.1 Cano Health Announces Change in Chief Financial Officer Role Eladio Gil named Interim Chief Financial Officer MIAMI, FL, September 29, 2023 /PRNewswire/— Cano Health, Inc. (“Cano Health”) (NYSE: CANO) today announced that Eladio Gil has been appointed Interim Chief Financial Officer, effective September 29, 2023. Mr. Gil, who previously served as Cano Health’s Vice President of Medica |
|
| September 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2023 (September 25, 2023) CANO HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-39289 98-1524224 (State or other jurisdiction of incorpor |
|
| September 29, 2023 |
Exhibit 10.1 Amendment to Employment Agreement This Amendment to Employment Agreement (the “Amendment”) is dated as of September 28, 2023 (the “Effective Date”) and is between Cano Health, LLC (d/b/a Cano Health), a Florida limited liability company (the “Company”) and Eladio Gil, an individual (the “Executive”). The Company and the Executive may each be referred to as a “Party” and collectively a |
|
| September 29, 2023 |
EX-2.1 Exhibit 2.1 EXECUTION VERSION ASSET PURCHASE AGREEMENT AMONG PRIMARY CARE HOLDINGS II, LLC CANO HEALTH, LLC, THE RELATED CONSOLIDATED ENTITIES, AND (SOLELY FOR THE LIMITED PURPOSES SET FORTH HEREIN) CANO HEALTH, INC. September 25, 2023 TABLE OF CONTENTS ARTICLE 1 DEFINITIONS 1 ARTICLE 2 PURCHASE OF ASSETS 17 2.1. Purchase; Purchase Price and Payment 17 2.2. Allocation 18 2.3. Assumed Liabil |
|
| September 26, 2023 |
Exhibit 99.1 Cano Health sells substantially all of its Primary Care Centers in Texas & Nevada to CenterWell Senior Primary Care MIAMI, FL, September 26, 2023 /PRNewswire/— Cano Health, Inc. (“Cano Health”) (NYSE: CANO) today announced that it sold substantially all of the assets associated with the operation of Cano Health’s senior-focused primary care centers in Texas and Nevada to CenterWell Se |
|
| September 26, 2023 |
Regulation FD Disclosure, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2023 (September 25, 2023) CANO HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-39289 98-1524224 (State or other jurisdiction of incorpor |
|
| September 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 11, 2023 (September 5, 2023) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware (State or other jurisdiction |
|
| September 11, 2023 |
Cano Health Announces Plans for Regaining Compliance with NYSE Stock Price Criteria Exhibit 99.1 Cano Health Announces Plans for Regaining Compliance with NYSE Stock Price Criteria MIAMI, FL, September 11, 2023 /PRNewswire/—Cano Health, Inc. (NYSE: CANO) (“Cano Health” or the “Company” announced today that it was notified by NYSE Regulation Inc. (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual (the “Listing Rule”) because the averag |
|
| September 8, 2023 |
CANO / Cano Health Inc - Class A / JPMORGAN CHASE & CO - FILING CANO HEALTH, INC. Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* Cano Health, Inc. (Name of Issuer) Class A common stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) August 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box t |
|
| September 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 8, 2023 (September 3, 2023) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other ju |
|
| August 28, 2023 |
CANO / Cano Health Inc - Class A / Hernandez Marlow - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value (Title of Class of Securities) 13781Y 103 (CUSIP Number) Dr. Marlow Hernandez c/o Cano Health, Inc. 9725 NW 117th Avenue, Suite 200 Miami, Florida 33178 (203) 422-7718 |
|
| August 23, 2023 |
CANO / Cano Health Inc - Class A / Diameter Capital Partners LP - SC 13D/A Activist Investment SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Cano Health, Inc. (Name of Issuer) Class A common stock, par value $0.0001 per share (Title of Class of Securities) 13781Y 103 (CUSIP Number) Diameter Capital Partners LP Attention: Shailini Rao 55 Hudson Yards, Suite 29B New York, NY 10001 (212) 655-1419 ( |
|
| August 21, 2023 |
EX-99.1 Exhibit 99.1 Cano Health Appoints Mark Kent Permanent Chief Executive Officer Mr. Kent immediately joins Board of Directors, replacing Dr. Marlow Hernandez who has stepped down MIAMI, August 21, 2023 /PRNewswire/ — Cano Health, Inc. (“Cano Health” or the “Company”), a leading value-based primary care provider and population health company, today announced that its Board of Directors has ap |
|
| August 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 21, 2023 (August 19, 2023) Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware 98-1524224 (State or other jurisd |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 8)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) ELLIOT COO |
|
| August 14, 2023 |
CANO / Cano Health Inc - Class A / STERNLICHT BARRY S - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 11)* Cano Health, Inc. (Name of Issuer) Class A common stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) Michael Racich 1601 Washington Avenue, Suite 800 Miami Beach, Florida 33139 (203) 422-7718 (Name, Address and Te |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 8)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) DR. LEWIS |
|
| August 11, 2023 |
Exhibit 99.1 Exhibit 1 JOINT FILING AGREEMENT The persons below hereby agree that the Schedule 13D to which this agreement is attached as an exhibit, as well as all future amendments to such Schedule 13D, shall be filed jointly on behalf of each of them. This agreement is intended to satisfy the requirements of Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934. Dated: August 11, 2023 |
|
| August 11, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2023 CANO HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-39289 98-1524224 (State or other jurisdiction of incorporation) (Commission File |
|
| August 11, 2023 |
EX-10.1 Exhibit 10.1 EXECUTION VERSION FIRST AMENDMENT TO CREDIT AGREEMENT FIRST AMENDMENT, dated as of August 10, 2023 (this “Amendment”), to the Credit Agreement, dated as of February 24, 2023 (as amended, supplemented, replaced or otherwise modified from time to time, the “Credit Agreement”), by and among Cano Health, LLC, a Florida limited liability company (the “Borrower”), Primary Care (ITC) |
|
| August 11, 2023 |
CANO / Cano Health Inc - Class A / Diameter Capital Partners LP - SC 13D Activist Investment SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment )* Cano Health, Inc. (Name of Issuer) Class A common stock, par value $0.0001 per share (Title of Class of Securities) 13781Y 103 (CUSIP Number) Diameter Capital Partners LP Attention: Shailini Rao 55 Hudson Yards, Suite 29B New York, NY 10001 (212) 655-1419 (Name, Add |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39289 Cano Health, Inc. (Ex |
|
| August 10, 2023 |
canohealth2q23financials 1 Cano Health 2Q23 Financial Supplement August 10, 2023 2 Disclaimer GENERAL: This presentation (“Presentation”) is for informational purposes only to assist investors, prospective investors and other parties (“Recipients”) in making their own evaluation with respect to Cano Health, Inc. |
|
| August 10, 2023 |
Exhibit 99.1 Cano Health Announces Financial Results for the Second Quarter 2023 Cano Health is pursuing a process to sell the Company The Company plans to exit operations in California, New Mexico and Illinois by the fall of 2023, and Puerto Rico by January 1, 2024 MIAMI, August 10, 2023 /PRNewswire/– Cano Health, Inc. (“Cano Health” or the “Company”) (NYSE: CANO), a leading value-based primary c |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 10, 2023 Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware (State or other jurisdiction of incorporation or or |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING 001-39289 (Commission File Number) (Check one): Form 10-K o Form 20-F o Form 11-K o Form 10-Q x Form 10-D o Form N-SAR o Form N-CSR o For Period Ended: June 30, 2023 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on |
|
| July 19, 2023 |
EXHIBIT O Concerned Shareholders of Cano Health Condemn the Board’s Egregious Conduct and Unwillingness to Accept a Resounding Rebuke at the 2023 Annual Meeting Group Holding ~35% Stake Issues Letter to Cano’s Stockholders Regarding the Current Board’s Latest Failures and the Importance of Continuing to Provide Feedback to the Failed Directors Questions the Current Board’s Ability to Maintain Credibility as it Continues Ignoring a Critical Mass of Stockholders Reaffirms Support for Interim Chief Executive Officer Mark Kent and Urges the Company to Pursue the Immediate Sale of Non-Core Assets to Pay Down Debt and Refocus Cano’s Strategy Reiterates Commitment to Sustaining a Campaign for Change, With the Goal of Ensuring Mr. |
|
| July 19, 2023 |
CANO / Cano Health Inc - Class A / STERNLICHT BARRY S - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 10)* Cano Health, Inc. (Name of Issuer) Class A common stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) Michael Racich 1601 Washington Avenue, Suite 800 Miami Beach, Florida 33139 (203) 422-7718 (Name, Address and Te |
|
| July 19, 2023 |
Exhibit 99.1 Concerned Shareholders of Cano Health Condemn the Board’s Egregious Conduct and Unwillingness to Accept a Resounding Rebuke at the 2023 Annual Meeting Group Holding ~35% Stake Issues Letter to Cano’s Stockholders Regarding the Current Board’s Latest Failures and the Importance of Continuing to Provide Feedback to the Failed Directors Questions the Current Board’s Ability to Maintain C |
|
| July 19, 2023 |
Exhibit 99.1 Concerned Shareholders of Cano Health Condemn the Board’s Egregious Conduct and Unwillingness to Accept a Resounding Rebuke at the 2023 Annual Meeting Group Holding ~35% Stake Issues Letter to Cano’s Stockholders Regarding the Current Board’s Latest Failures and the Importance of Continuing to Provide Feedback to the Failed Directors Questions the Current Board’s Ability to Maintain C |
|
| July 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 7)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) Dr. Lewis |
|
| July 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 7)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) ELLIOT COO |
|
| July 17, 2023 |
EX-99.4 Exhibit 99.4 PURCHASE AGREEMENT THIS PURCHASE AGREEMENT (the “Agreement”) is entered into by and between the Cano Health, LLC, a Florida limited liability company on behalf of itself and its designated subsidiaries and controlled network affiliates under risk-sharing contracts with capitated health plans including Medicare Advantage Plans that have contracted with the Centers for Medicare |
|
| July 17, 2023 |
FIRST AMENDMENT TO PURCHASE AGREEMENT EX-99.5 Exhibit 99.5 FIRST AMENDMENT TO PURCHASE AGREEMENT This First Amendment to Purchase Agreement (this “Amendment”) is entered into by and between the Cano Health, LLC, a Florida limited liability company on behalf of itself and its designated subsidiaries and controlled network affiliates under risk-sharing contracts with capitated health plans including Medicare Advantage Plans that have co |
|
| July 17, 2023 |
US5537451008 / MSP RECOVERY INC / Cano Health, Inc. - SC 13D Activist Investment SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, Florida 33178 Tel: (855) 226-6633 |
|
| July 17, 2023 |
FIRST AMENDMENT TO AMENDED AND RESTATED CLAIMS RECOVERY AND ASSIGNMENT AGREEMENT EX-99.2 Exhibit 99.2 FIRST AMENDMENT TO AMENDED AND RESTATED CLAIMS RECOVERY AND ASSIGNMENT AGREEMENT THIS FIRST AMENDMENT TO AMENDED AND RESTATED CLAIMS RECOVERY AND ASSIGNMENT AGREEMENT (this “Amendment”), effective as of September 30, 2022 (the “Effective Date”), is entered into by and among Cano Health, LLC, a Florida limited liability company, on behalf of itself and its designated subsidiari |
|
| July 17, 2023 |
SECOND AMENDMENT TO AMENDED AND RESTATED CLAIMS RECOVERY AND ASSIGNMENT AGREEMENT EX-99.3 Exhibit 99.3 SECOND AMENDMENT TO AMENDED AND RESTATED CLAIMS RECOVERY AND ASSIGNMENT AGREEMENT THIS SECOND AMENDMENT TO AMENDED AND RESTATED CLAIMS RECOVERY AND ASSIGNMENT AGREEMENT (this “Second Amendment”), effective as of March 31, 2023 (the “Effective Date”), is entered into by and among Cano Health, LLC, a Florida limited liability company, on behalf of itself and its designated subsi |
|
| July 17, 2023 |
AMENDED AND RESTATED CLAIMS RECOVERY AND ASSIGNMENT AGREEMENT EX-99.1 Exhibit 99.1 AMENDED AND RESTATED CLAIMS RECOVERY AND ASSIGNMENT AGREEMENT THIS AMENDED AND RESTATED CLAIMS RECOVERY AND ASSIGNMENT AGREEMENT (the “Agreement”) is entered into by and between Cano Health, LLC, a Florida limited liability company, on behalf of itself and its designated subsidiaries and controlled network affiliates under risk-sharing contracts with capitated health plans inc |
|
| June 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2023 CANO HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-39289 98-1524224 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 20, 2023 |
EX-10.2 Exhibit 10.2 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”), dated as of December 13, 2022, is effective as of the Commencement Date (defined below) between Canon Health, LLC (the “Company”), and deMarquette Kent, an individual (the “Executive”). 1. Employment. (a) Term. The Company hereby employs the Executive, and the Executive hereby accepts such employment, on the ter |
|
| June 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| June 20, 2023 |
CANO / Cano Health Inc - Class A / Hernandez Marlow - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value (Title of Class of Securities) 13781Y 103 (CUSIP Number) Dr. Marlow Hernandez c/o Cano Health, Inc. 9725 NW 117th Avenue, Suite 200 Miami, Florida 33178 (203) 422-7718 |
|
| June 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2023 (June 16, 2023) CANO HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-39289 98-1524224 (State or other jurisdiction of incorporation) (Co |
|
| June 20, 2023 |
EX-10.1 Exhibit 10.1 June 16, 2023 deMarquette Kent At the Address on File with the Company Re: Interim Chief Executive Officer Agreement Dear Mark: On behalf of Cano Health, Inc. (the “Parent”) and Cano Health LLC (the “Company” and together with the Parent, the “Company Group”), I am pleased to offer you the position of Chief Executive Officer of the Company Group on an interim basis (“Interim C |
|
| June 20, 2023 |
EX-99.1 Exhibit 99.1 Cano Health Announces Leadership Change to Advance Execution of Value Creation Plan Mark Kent appointed Interim Chief Executive Officer Dr. Marlow Hernandez has agreed to step down immediately as Chief Executive Officer and remain on the Board of Directors Launches search to identify permanent CEO and to refresh the Board with additional new independent directors MIAMI, June 1 |
|
| June 20, 2023 |
EX-10.4 Exhibit 10.4 EXECUTION VERSION June 18, 2023 Dr. Marlow Hernandez At the Address on File with the Company Re: Treatment of Equity Awards Dear Marlow: This letter confirms the treatment of your equity awards outstanding under the Cano Health, Inc. 2021 Stock Option and Incentive Plan (the “Parent” and the “Plan,” respectively) in connection with your termination of employment from Cano Heal |
|
| June 20, 2023 |
EX-10.3 Exhibit 10.3 EXECUTION VERSION Separation Agreement and Release of Claims This Separation Agreement and Release of Claims (the “Release”) is entered into by and among Cano Health, LLC (the “Company”), Cano Health, Inc. (the “Parent”), and Marlow Hernandez (the “Executive”) (collectively, the “Parties”) in connection with the “Employment Agreement” among the Executive, the Company and the P |
|
| June 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| June 16, 2023 |
EX-99.1 Exhibit 99.1 Cano Health Announces Results of Annual Stockholders’ Meeting Dr. Alan Muney and Kim Rivera re-elected to Board of Directors MIAMI, June 15, 2023 – Cano Health, Inc. (“Cano Health” or the “Company”), a leading value-based primary care provider and population health company, today announced the results of its Annual Stockholders’ Meeting (the “Annual Meeting”). Based on the vot |
|
| June 16, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2023 CANO HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-39289 98-1524224 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 15, 2023 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| June 8, 2023 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| June 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| June 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| June 7, 2023 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| June 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 31, 2023 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| May 31, 2023 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| May 31, 2023 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| May 30, 2023 |
EXHIBIT 1 - INVESTOR PRESENTATION The Urgent Need for Changes in Leadership and Strategy at Cano Health Prepared by the Concerned Shareholders of Cano Health May 2023Concerned Shareholders of Cano Health The materials contained herein (the “Materials”) represent the opinions of Elliot Cooperstone, Lewis Gold, Barry S. |
|
| May 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 26, 2023 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| May 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 26, 2023 |
Vote WITHHOLD on Cano Health Directors Today! Concerned Shareholders of Cano Urge All Holders to Send a Clear Message About the Immediate Need for Change Dr. |
|
| May 25, 2023 | ||
| May 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6 |
|
| May 22, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| May 22, 2023 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| May 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a- |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 6)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) Dr. Lewis |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 6)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) ELLIOT COO |
|
| May 19, 2023 |
Exhibit 99.1 Concerned Shareholders of Cano Health Nominate Highly Qualified, Independent Director Candidates and Propose Removal of Dr. Marlow Hernandez from Board for Cause Group Details the Case for Urgent Change at Cano Following an Extended Period of Underperformance, Failed Capital Allocation, and Extremely Poor Governance and Strategic Execution Urges Stockholders to WITHHOLD Support for In |
|
| May 19, 2023 |
Exhibit 99.1 Concerned Shareholders of Cano Health Nominate Highly Qualified, Independent Director Candidates and Propose Removal of Dr. Marlow Hernandez from Board for Cause Group Details the Case for Urgent Change at Cano Following an Extended Period of Underperformance, Failed Capital Allocation, and Extremely Poor Governance and Strategic Execution Urges Stockholders to WITHHOLD Support for In |
|
| May 19, 2023 |
Joint Filing and Solicitation Agreement Exhibit 99.2 Joint Filing and Solicitation Agreement WHEREAS, certain of the undersigned are stockholders, direct or beneficial, of Cano Health, Inc., a Delaware corporation (the “Company”); WHEREAS, ITC Rumba, LLC and Elliot Cooperstone (collectively, “ITC Rumba”), EGGE, LLC, EG Advisors, LLC and Lewis Gold (collectively, “EGGE”), and Jaws Equity Owner 146, LLC and Barry Sternlicht (collectively, |
|
| May 19, 2023 |
JOINT FILING AND SOLICITATION AGREEMENT EXHIBIT N JOINT FILING AND SOLICITATION AGREEMENT WHEREAS, certain of the undersigned are stockholders, direct or beneficial, of Cano Health, Inc. |
|
| May 19, 2023 |
EXHIBIT M Concerned Shareholders of Cano Health Nominate Highly Qualified, Independent Director Candidates and Propose Removal of Dr. |
|
| May 19, 2023 |
Form of Indemnification Agreement ITC RUMBA, LLC One Vanderbilt Avenue, Suite 2400 New York, New York 10017 May 18, 2023 Re: Cano Health, Inc. |
|
| May 19, 2023 |
Joint Filing and Solicitation Agreement Exhibit 99.2 Joint Filing and Solicitation Agreement WHEREAS, certain of the undersigned are stockholders, direct or beneficial, of Cano Health, Inc., a Delaware corporation (the “Company”); WHEREAS, ITC Rumba, LLC and Elliot Cooperstone (collectively, “ITC Rumba”), EGGE, LLC, EG Advisors, LLC and Lewis Gold (collectively, “EGGE”), and Jaws Equity Owner 146, LLC and Barry Sternlicht (collectively, |
|
| May 19, 2023 |
CANO / Cano Health Inc - Class A / STERNLICHT BARRY S - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 9)* Cano Health, Inc. (Name of Issuer) Class A common stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) Michael Racich 1601 Washington Avenue, Suite 800 Miami Beach, Florida 33139 (203) 422-7718 (Name, Address and Tel |
|
| May 18, 2023 |
CORRESP May 18, 2023 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Mergers & Acquisitions 100 F Street, N.E. Washington, D.C. 20549 Attention: Nicholas Panos Re: Cano Health, Inc. PRER14A - Amendment No. 2 to Preliminary Proxy Statement Filed May 15, 2023 File No. 001-39289 Dear Mr. Panos: This letter is submitted on behalf of Cano Health, Inc. (the “Company,” “ |
|
| May 18, 2023 |
CANO HEALTH, INC. 9,899,973 Shares of Class A Common Stock Offered by the Selling Stockholders 424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-270578 PROSPECTUS CANO HEALTH, INC. 9,899,973 Shares of Class A Common Stock Offered by the Selling Stockholders This prospectus relates to the proposed resale or other disposition by the selling stockholders identified in this prospectus of up to an aggregate of 9,899,973 shares of Class A common stock, par value $0.000 |
|
| May 18, 2023 |
424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-270580 PROSPECTUS CANO HEALTH, INC. Up to 29,483,101 Shares of Class A Common Stock Offered by the Selling Stockholders This prospectus relates to the potential resale from time to time of some or all of the 29,483,101 shares of Class A common stock, par value $0.0001 per share, of Cano Health, Inc. that have been issued |
|
| May 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 17, 2023 |
As filed with the Securities and Exchange Commission on May 17, 2023 S-3/A As filed with the Securities and Exchange Commission on May 17, 2023 Registration No. |
|
| May 17, 2023 |
As filed with the Securities and Exchange Commission on May 17, 2023 S-3/A As filed with the Securities and Exchange Commission on May 17, 2023 Registration No. |
|
| May 16, 2023 |
Cano Health, Inc. 9725 NW 117th Avenue Suite 200 Miami, FL 33178 CORRESP Cano Health, Inc. 9725 NW 117th Avenue Suite 200 Miami, FL 33178 May 16, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Jordan Nimitz Re: Cano Health, Inc. Acceleration Request for Registration Statement on Form S-3, as amended File No. 333-270580 Requ |
|
| May 16, 2023 |
Cano Health, Inc. 9725 NW 117th Avenue Suite 200 Miami, FL 33178 CORRESP Cano Health, Inc. 9725 NW 117th Avenue Suite 200 Miami, FL 33178 May 16, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Jordan Nimitz Re: Cano Health, Inc. Acceleration Request for Registration Statement on Form S-3, as amended File No. 333-270578 Requ |
|
| May 15, 2023 |
CORRESP Attorney Work Product Privileged & Confidential May 15, 2023 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Mergers & Acquisitions 100 F Street, N.E. Washington, D.C. 20549 Attention: Nicholas Panos Re: Cano Health, Inc. PRE 14A - Preliminary Proxy Statement Filed May 2, 2023 File No. 001-39289 Dear Mr. Panos: This letter is submitted on behalf of Cano He |
|
| May 15, 2023 |
CANO / Cano Health Inc - Class A / STERNLICHT BARRY S - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8)* Cano Health, Inc. (Name of Issuer) Class A common stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) Michael Racich 1601 Washington Avenue, Suite 800 Miami Beach, Florida 33139 (203) 422-7718 (Name, Address and Tel |
|
| May 15, 2023 |
EXHIBIT L Concerned Shareholders of Cano Health Launch Director Withhold Campaign at the Company’s 2023 Annual Meeting Major Shareholder Group Believes Cano is a Great Business Held Back by an Entrenched Board and Management That Have Lost Credibility and Destroyed Value Exposes Cano’s Ongoing Efforts to Muzzle Shareholders by Refusing to Reopen the Window for Nominating Director Candidates and Submitting Proposals at Annual Meeting Highlights That Group Has Brought a Lawsuit – for the Benefit of All Shareholders – to Compel the Board to Reverse Course by Reopening the Window Files Preliminary Proxy and Urges Shareholders to WITHHOLD Support for Dr. |
|
| May 15, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 2) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Revised Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted b |
|
| May 15, 2023 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| May 12, 2023 |
CANO / Cano Health Inc - Class A / Gold Lewis - PRESS RELEASE AND LETTER Activist Investment begin 644 ex991to13da513778002051223.pdf M)5!$1BTQ+C8-)>+CS],-"C,R(# @;V)J#3P\+TQI;F5A7!E+T-A=&%L;V<^/@UE;F1O8FH- M,S0@,"!O8FH-/#PO07)T0F]X6S @," V,3(@-SDR72]";&5E9$)O>%LP(# @ M-C$R(#%LP(# @-C$R M(#7!E+U!A9V4^/@UE;F1O8FH-,S4@,"!O8FH-/#PO1FEL=&5R+T9L871E1&5C M;V1E+T9I7!E+T]B:E-T;3X^]HGY)G#A2A02T=&W'BA:T%R$^I-2CT=($A73J MOWNG(2&% JE4W3R^>Y\=W[\V%$<."@!0OJ@) C/!>6 E#BXX&@/E +EH\\# M'RW*QTB-4PW"U0)4 " |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 5)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) Dr. Lewis |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 5)1 Cano Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 13781Y103 (CUSIP Number) Elliot Coo |
|
| May 12, 2023 |
CANO / Cano Health Inc - Class A / Cooperstone Elliot - PRESS RELEASE AND LETTER Activist Investment begin 644 ex991to13da513756002051223.pdf M)5!$1BTQ+C8-)>+CS],-"C,R(# @;V)J#3P\+TQI;F5A7!E+T-A=&%L;V<^/@UE;F1O8FH- M,S0@,"!O8FH-/#PO07)T0F]X6S @," V,3(@-SDR72]";&5E9$)O>%LP(# @ M-C$R(#%LP(# @-C$R M(#7!E+U!A9V4^/@UE;F1O8FH-,S4@,"!O8FH-/#PO1FEL=&5R+T9L871E1&5C M;V1E+T9I7!E+T]B:E-T;3X^]HGY)G#A2A02T=&W'BA:T%R$^I-2CT=($A73J MOWNG(2&% JE4W3R^>Y\=W[\V%$<."@!0OJ@) C/!>6 E#BXX&@/E +EH\\# M'RW*QTB-4PW"U0)4 " |
|
| May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi |
|
| May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confide |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2023 Cano Health, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 001-39289 Delaware (State or other jurisdiction of incorporation or organi |
